In particular, pro-inflammatory cytokines, such as IL-1α [36], IL-1β [37], IL-6 [38, 39], TNF [36, 38] and MIP-1β [36], are upregulated in the serum or BM of CML patients. Here, IL1A is linked to chronic myelogenous leukemia, BCR-ABL1 positive.